Your browser doesn't support javascript.
loading
Effectiveness and safety of Omalizumab in the treatment of chronic spontaneous urticaria: Systematic review and meta-analysis.
Rubini, N P M; Ensina, L F C; Silva, E M K; Sano, F; Solé, D.
Afiliación
  • Rubini NPM; School of Medicine and Surgery, Federal University of the State of Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil. Electronic address: norma.rubini@gmail.com.
  • Ensina LFC; Division of Allergy, Clinical Immunology and Rheumatology, Department of Pediatrics, Escola Paulista de Medicina, Federal University of São Paulo (EPM-UNIFESP), São Paulo, Brazil. Electronic address: 100alergia@gmail.com.
  • Silva EMK; Division of Emergency and Evidence Based Medicine, EPM-UNIFESP and Researcher of Cochrane Center of Brazil, São Paulo, Brazil. Electronic address: edinaksilva@terra.com.br.
  • Sano F; Nipo-Brazilian Hospital, São Paulo, Brazil. Electronic address: flaviosano@globo.com.
  • Solé D; Division of Allergy, Clinical Immunology and Rheumatology, Department of Pediatrics, EPM-UNIFESP, São Paulo, Brazil. Electronic address: dirceu.sole@unifesp.br.
Allergol Immunopathol (Madr) ; 47(6): 515-522, 2019.
Article en En | MEDLINE | ID: mdl-31607407
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antialérgicos / Omalizumab / Urticaria Crónica / Inmunoterapia Tipo de estudio: Clinical_trials / Systematic_reviews Límite: Humans Idioma: En Revista: Allergol Immunopathol (Madr) Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antialérgicos / Omalizumab / Urticaria Crónica / Inmunoterapia Tipo de estudio: Clinical_trials / Systematic_reviews Límite: Humans Idioma: En Revista: Allergol Immunopathol (Madr) Año: 2019 Tipo del documento: Article